🔗 Share this article Patients Discontinuing Slimming Jabs Regain Pounds at a Quadrupled Rate Than Those on Conventional Diets Obesity treatment often requires ongoing approaches. A recent study reveals that patients who stop using popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who end traditional lifestyle programs. Research printed in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping. "Individuals using these drugs must be informed of the danger of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb. This pace of recovery means a return to original weight in about 18 months. Analyzing Therapies The study, which looked at 37 of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting. The team note that individuals who lose weight through dieting typically experience a less rapid creep back—around 0.1 kg a month—once they finish. Understanding the Fast Rebound Doctors propose the way of the injections is key to understanding the heightened regain. The injections mimic a natural hormone called GLP-1, which helps regulate feelings of fullness. "Long-term administration of the hormone levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher. "Withdrawal of this hormone supplement results in appetite is uncontrolled, making excessive eating much more probable." A Lifelong Condition? Health authorities suggest the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications. A number of clinicians contend that, due to the significant potential of relapse, the treatment should be considered ongoing. This perspective is reinforced by pharmaceutical companies, who say that the findings "underscore the persistent character of excess weight," comparing it to managing conditions like diabetes. User Testimonies People who have come off the jabs explain a intense resurgence of cravings. "I experienced something flipping and you become extremely hungry," said a patient. This difficulty is worsened if patients have not adopted lasting lifestyle or habit changes during therapy. Significant Interest Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow. Use is more common among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the medications through private healthcare rather than public health services. Ultimately, researchers emphasize that while these medications are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on ongoing behavioural changes.
Obesity treatment often requires ongoing approaches. A recent study reveals that patients who stop using popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who end traditional lifestyle programs. Research printed in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping. "Individuals using these drugs must be informed of the danger of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb. This pace of recovery means a return to original weight in about 18 months. Analyzing Therapies The study, which looked at 37 of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting. The team note that individuals who lose weight through dieting typically experience a less rapid creep back—around 0.1 kg a month—once they finish. Understanding the Fast Rebound Doctors propose the way of the injections is key to understanding the heightened regain. The injections mimic a natural hormone called GLP-1, which helps regulate feelings of fullness. "Long-term administration of the hormone levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher. "Withdrawal of this hormone supplement results in appetite is uncontrolled, making excessive eating much more probable." A Lifelong Condition? Health authorities suggest the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications. A number of clinicians contend that, due to the significant potential of relapse, the treatment should be considered ongoing. This perspective is reinforced by pharmaceutical companies, who say that the findings "underscore the persistent character of excess weight," comparing it to managing conditions like diabetes. User Testimonies People who have come off the jabs explain a intense resurgence of cravings. "I experienced something flipping and you become extremely hungry," said a patient. This difficulty is worsened if patients have not adopted lasting lifestyle or habit changes during therapy. Significant Interest Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow. Use is more common among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the medications through private healthcare rather than public health services. Ultimately, researchers emphasize that while these medications are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on ongoing behavioural changes.